Search bioRxiv⌕ Search

Biology subjects

Hopkins, N.

Publications and source records attributed to Hopkins, N..

2 recordsLinked to original sources

Differential regulation of myeloid Scavenger Receptor A (CD204) expression in humans versus mice in response to sepsis

Sepsis is the number one cause of mortality in the critically ill patient. The underlying pathophysiology of sepsis is not fully understood. Scavenger Receptor A (SR-A) is a promiscuous receptor of myeloid cells that binds multiple pathogen associated molecular patterns (PAMPs). We have demonstrated that SR-A promotes mortality in murine sepsis. The present study sought to examine the effect of sepsis on myeloid SR-A expression in septic mice and compare it to sepsis patients. Leukocytes were isolated from mice after cecal ligation and puncture. Blood leukocytes were isolated from sepsis patients. Myeloid cells were isolated from healthy mice or human subjects and were treated with PAMPs. Leukocyte phenotype and SR-A expression were determined by flow cytometry. CLP increased SR-A expression when compared to sham operated animals on both neutrophils and monocytes/macrophages. In contrast, SR-A expression was not changed on either neutrophils or monocytes from sepsis patients when compared to healthy control subjects. Treatment of murine neutrophils and macrophages with Pam3CSK4 and treatment of macrophages with LPS increased SR-A expression. Human neutrophil SR-A expression was not altered by any PAMPs, and only treatment with C. albicans glucan increased SR-A expression on human monocytes. Myeloid SR-A expression is increased in septic mice, and this increase plays a detrimental role in the response to sepsis, while SR-A expression is not changed in leukocytes from septic patients and does not correlate with SOFA II scores. Thus, myeloid SR-A expression does not appear to play significant a role in the pathophysiology of human sepsis.

immunology↗

A Single-Cell Framework for Classifying Human Th17 Pathogenicity Links Acylcarnitine Metabolism to Non-Pathogenic Inflammation in Type 2 Diabetes

Based on in vitro and animal studies, Th17 cells are classified as pathogenic (pTh17) or non-pathogenic (nTh17), but the inability to identify these subsets in primary human samples limits translation. We developed a single-cell ELISA to enrich human Th17s, enabling transcriptomic and flow-cytometric classification. nTh17 cells predominated in Type 2 diabetes and exhibited signatures of acylcarnitine synthesis, while knockdown of CPT1A demonstrated that acylcarnitine metabolism regulates Th17 pathogenicity.

immunology↗